High-Level Panel on Access to Medicines
United Nations Secretary-General’s High-Level Panel on Access to Medicines calls for New Deal to close the Health Innovation and Access Gap
Whether it’s the rising price of the EpiPen, or new outb...
50 Years of EU-pharmaceutical regulation
“2015 marks the 50th anniversary of the adoption of the first law on the authorisation of pharmaceuticals at EU level, which set the basis for some of the key principles that are still valid today....
ANME response Matrix Report-Herbals
by the PHARMACEUTICAL COMMITTEE of the EU-Commission (Health systems and products- Medicinal products – authorizations, European Medicines Agency) in relation to the Matrix-Report of 2012, referrin...
Summary of comments to study on availability of medicines for human use
Agenda item 2d
PHARMACEUTICAL COMMITTEE – 22 October 2014
The Pharmaceutical Committee was asked1 to provide feedback on the study report, in terms of appreciation of the correctness of the analy...
Traditional Herbal Medicinal Products in Europe and the World
TradeReg-Symposium 2013
by Dr. Mathias Schmidt (ANME+EUAA)
From 30 September to 2 October the symposium “TradeReg 2013: Regulation of Herbal and Traditional Medicinal Products – European and gl...